Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...
Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...
16don MSN
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...
Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...
The PROSTaid group, which meets monthly at The Cradock Arms in Leicester, aims to create a support group for men so they can ...
Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
An Alabama Senate bill advances to mandate insurance coverage for prostate cancer screenings, potentially improving early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results